Challenges of NTM Drug Development

Simple item page
dc.contributor.authorFalkinham, Joseph O. IIIen
dc.contributor.departmentBiological Sciencesen
dc.date.accessioned2019-03-14T14:19:49Zen
dc.date.available2019-03-14T14:19:49Zen
dc.date.issued2018-07-18en
dc.description.abstractDiscovery and development of antibiotics active against the environmental opportunistic non-tuberculous mycobacteria (NTM) have been retarded by innate antibiotic-resistance of NTM cells and methodological challenges in the laboratory. The basis for the innate resistance of NTM cells is its lipid rich outer membrane that results in hydrophobic cells and the outer membrane's impermeability, and the residence of NTM cells in phagocytic cells, and the slow growth and dormancy of NTM. Laboratory challenges include: the choice of species and strains for screening and measurement of anti-NTM activity, the high frequency colony switching between antibiotic-susceptible and resistant variants, the preference of NTM to adhere to surfaces and form biofilms, and the aggregation of NTM cells. Understanding these challenges can guide and inform our approaches to discovery and development of antibiotics with activity against NTM.en
dc.format.mimetypeapplication/pdfen
dc.identifier.doihttps://doi.org/10.3389/fmicb.2018.01613en
dc.identifier.issn1664-302Xen
dc.identifier.other1613en
dc.identifier.pmid30072975en
dc.identifier.urihttp://hdl.handle.net/10919/88439en
dc.identifier.volume9en
dc.language.isoen_USen
dc.publisherFrontiersen
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.titleChallenges of NTM Drug Developmenten
dc.title.serialFrontiers in Microbiologyen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
fmicb-09-01613.pdf
Size:
230.26 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Scholarly Works, Biological Sciences